Crohn's Disease Newswire (Page 4)

Crohn's Disease Newswire (Page 4)

Comprehensive Real-Time News Feed for Crohn's Disease. (Page 4)

Results 61 - 80 of 2,192 in Crohn's Disease

  1. Woman sues Costco after contracting E. coli from tainted chickenRead the original story w/Photo

    Wednesday Aug 9 | New York Post

    ... to an intensive care unit shortly after. "They were checking me for lupus, they were checking me for Crohn's disease, or a combination of a bunch of different diseases. Nothing was adding up until we got a call from the FDA asking if we'd consumed ...

    Comment?

  2. Could a protein-rich diet soothe an inflamed gut?Read the original story w/Photo

    Wednesday Aug 9 | Manawatu Evening Standard

    ... may induce expansion of this population." Inflammatory bowel disease (IBD - the term used to describe Crohn's disease and ulcerative colitis) affects about one in 250 people aged five to 40. "There is little evidence to suggest that dietary factors ...

    Comment?

  3. Costco sued by woman who contracted E. coli from tainted chickenRead the original story

    Wednesday Aug 9 | Fox News

    ... to an intensive care unit shortly after. "They were checking me for lupus, they were checking me for Crohn's disease, or a combination of a bunch of different diseases. Nothing was adding up until we got a call from the FDA asking if we'd consumed ...

    Comment?

  4. World's oldest family says this breakfast staple is the key to a long lifeRead the original story w/Photo

    Tuesday Aug 1 | MSN Healthy Living

    ... getting diabetes by 21 percent and also lowered their risk for inflammatory conditions like arthritis, gout, Crohn's disease and neurodegenerative diseases, among others. A study of nurses also found that women who ate two to three servings of ...

    Comment?

  5. Kymab Announces Clinical Update On Its Promising New Antibody KY1005...Read the original story

    Monday Jul 31 | BioSpace

    ... arthritis, psoriasis, multiple sclerosis (MS), lupus and inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. KY1005, a fully human monoclonal antibody, is a potential first-in-class therapeutic that may address an ...

    Comment?

  6. TiGenix Release: Transparency InformationRead the original story

    Monday Jul 31 | BioSpace

    ... III clinical trial for the treatment of complex perianal fistulas - a severe, debilitating complication of Crohn's disease. Cx601 has been filed for regulatory approval in Europe and a global Phase III trial intended to support a future U.S. ...

    Comment?

  7. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells...Read the original story w/Photo

    Monday Jul 31 | BioMed Central

    ... [ ]. IBS is reportedly also present in in about 50% of patients with ulcerative colitis patients and Crohn's disease in remission [ The etiology of IBS is unclear, but certain factors appear to play a pivotal role in its pathophysiology, including ...

    Comment?

  8. Arena To Release Second Quarter 2017 Financial Results And Provide...Read the original story

    Monday Jul 31 | BioSpace

    ... ulcerative colitis (UC), and APD371 in Phase 2 evaluation for the treatment of pain associated with Crohn's disease. In addition, Arena has collaborations with the following pharmaceutical companies: Eisai Co., Ltd. and Eisai Inc. (commercial ...

    Comment?

  9. Alphonso Mangoes - " Courtesy of Flickr/Ramnath BhatRead the original story w/Photo

    Tuesday Aug 1 | Egypt Today

    According to the American medical website MedicalXpress, a team of researchers under the leadership of Dr. Susanne Talcott, Texas research scientist, found out that that inflammatory bowel disease is a serious sign of colon cancer, as the most common forms of that disorder are Crohn's Disease and Ulcerative colitis. Earlier studies showed that around 1.5 million people suffer from inflammatory bowel disease in the United States and around 2.2 million suffer from it in Europe and other countries.

    Comment?

  10. Living on a farm found to drastically reduce the risk of inflammatory bowel diseaseRead the original story w/Photo

    Monday Jul 31 | NewsTarget.com

    A Canadian study concludes, yet again, that urbanization influences the development of intestinal microbiomes. The gut bacteria plays a direct role in the occurrence of illnesses such as inflammatory bowel disease , which includes Crohn's disease and ulcerative colitis.

    Comment?

  11. Micro-Guests' Role in Pathologic ProcessesRead the original story w/Photo

    Monday Jul 31 | Newswise

    ... interventions to treat and/or prevent IBD. A clinically effective dietary intervention specifically for Crohn's disease (a form of IBD) is exclusive enteral nutrition (EEN), which consists of amino acids, simple carbohydrates, and triglycerides. ...

    Comment?

  12. Crohn's disease can be a factor in B12 deficiencyRead the original story w/Photo

    Monday Jul 31 | Brunswick News

    I'm living with Crohn's disease. Even though I feel fine, my wife is certain that it has caused me to be vitamin B12 deficient.

    Comment?

  13. Dr. Robert Burakoff Named to Leadership Roles in Gastroenterology at...Read the original story w/Photo

    Monday Jul 31 | Newswise

    ... Medicine. Dr. Burakoff's primary expertise is in chronic inflammation of the digestive tract, including Crohn's disease and ulcerative colitis - the primary forms of IBD. As a clinical researcher, he is conducting translational research using ...

    Comment?

  14. Anti-TNF treatment in Crohn's disease and risk of bowel resectionRead the original story

    Monday Jul 31 | GastroHep.com

    A study published ahead of print in the Alimentary Pharmacology & Therapeutics evaluates the association between anti-TNF treatment in Crohn's disease and risk of bowel resection. TNF inhibitors have been shown to reduce the need for surgery in Crohn's disease, but few studies have examined their effect beyond the first year of treatment.

    Comment?

  15. Arena Pharmaceuticals LogoRead the original story w/Photo

    Monday Jul 31 | PR Newswire

    ... ulcerative colitis (UC), and APD371 in Phase 2 evaluation for the treatment of pain associated with Crohn's disease. In addition, Arena has collaborations with the following pharmaceutical companies: Eisai Co., Ltd. and Eisai Inc. (commercial ...

    Comment?

  16. Country Kids Less Likely to Develop Bowel Disease Than Their City CousinsRead the original story w/Photo

    Monday Jul 31 | HON

    ... the number of very young children diagnosed with IBD has jumped in the past 20 years. IBD -- which includes Crohn's disease and ulcerative colitis -- is a lifelong condition that causes inflammation in the digestive tract, resulting in chronic ...

    Comment?

  17. Pediatric Vitamin B12 Deficiency: When Autism Isn't AutismRead the original story

    Feb 18, 2014 | Pharmacy Times

    ... due to any cause (ie, vegetarianism, autoimmune pernicious anemia, celiac disease, Helicobacter pylori , Crohn's disease, gastric bypass, partial ileectomy, eating disorders, or use of proton-pump inhibitors, histamine2 blockers, metformin, or ...

    Comment?

  18. Stem cells may help improve corneal wound healingRead the original story w/Photo

    Monday Jul 31 | PhysOrg Weblog

    ... yet that brain ... Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

    Comment?

  19. RedHill Biopharma Announces Unanimous Positive DSMB Recommendation...Read the original story

    Monday Jul 31 | B3C

    The independent Data and Safety Monitoring Board reviewed safety and efficacy data, of which RedHill remains blinded, from the first 222 subjects who have completed week 26 assessments in the Phase III MAP US study An open-label extension Phase III study is ongoing in parallel in patients who remain out of remission after 26 weeks of blinded study therapy in the MAP US study Tel-Aviv, Israel / Raleigh, NC, USA, July 31, 2017 / B3C newswire / -- RedHill Biopharma Ltd. , a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today reported, following a second pre-planned meeting to assess the safety and efficacy data from its ongoing first Phase III study with RHB-104 for Crohn's disease by an independent Data and ... (more)

    Comment?

  20. Redhill Biopharma Ltd. (NASDAQ:RDHL) Stock Rating Upgraded by Zacks Investment ResearchRead the original story w/Photo

    Saturday Jul 29 | IntersportsWire

    ... includes: RHB-105 - a combination therapy for H.pylori infection; RHB-104 - a combination therapy for Crohn's disease and multiple sclerosis; BEKINDA - a once-daily oral formulation of ondansetron for acute gastroenteritis and IBS-D; RHB-106 - an ...

    Comment?